Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Medical Device Network5d agoneutral
Spinal cord stimulator lawsuits surge: what is going wrong?Investing.com6d agoneutral
Fox’s $22 billion Roku deal poised to clear U.S. antitrust review - SemaforThe Wall Street Journal39d agoneutral
Paramount Settlement of Antitrust Case Approved by JudgeSimply Wall St.41d agoneutral
Is AbbVie (ABBV) A Bargain After FDA Approval Of JUVMO For Parkinson's?24/7 Wall St.42d agoneutral
Eli Lilly Just Won FDA Approval for a Once Weekly Insulin and the Stock Is Knocking on $1,200Insider Monkey46d agoneutral
Paramount Settled the Warner Bros. Antitrust Fight. Is the Deal Finally Close?The Wall Street Journal47d agoneutral
The Morning Risk Report: Paramount Settles States’ Antitrust Suit, Clearing Way for Warner MegadealThe Wall Street Journal48d agoneutral
Paramount Settles States’ Antitrust Suit, Clearing Way for Warner MegadealInvestor's Business Daily48d agoneutral
Paramount, Warner Bros. Rally On Promising Settlement Talks With California AGMotley Fool66d agoneutral
Opinion: Google's Latest Antitrust Ruling Is a Big Win for Alphabet InvestorsSimply Wall St.69d agoneutral
Eli Lilly (LLY) Stock May Be 30% Undervalued Despite Fresh FDA ApprovalThe Wall Street Journal72d agoneutral
Google Tweaks Site Ranking Policy in Most of Europe to Avert Antitrust FineBenzinga73d agoneutral
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose TrackingInsider Monkey73d agoneutral
New FDA Approval Gives Bristol-Myers Squibb (BMY) Another Potential Oncology Growth CatalystBenzinga Private Markets73d agoneutral
KKR Hit With $250 Million Penalty Over Antitrust Violations